Effect of high-definition brain stimulation on non-suicidal self-injury
Official title: Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI)
Run by Anhui Medical University · NCT06127056 · Data updated 2026-11-12
This study is testing if a special type of brain stimulation can help teenagers who hurt themselves without wanting to die feel better and understand their behavior better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Anhui Medical University Academic / other |
| Locations | 1 site (Hefei, Anhui) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | August 30, 2026 |
| Study ends | August 30, 2026 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT06127056 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 12-18 diagnosed with non-suicidal self-injury who have not changed their medication in the past month.
✕Probably not a fit
Patients with suicidal ideation, neurological disorders, or a history of substance abuse may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of high-definition transcranial alternating current stimulation (HD-tACS) on patients aged 12-18 who engage in non-suicidal self-injury (NSSI). Forty participants diagnosed with NSSI will receive either active or sham HD-tACS treatment over a week, with assessments conducted before and after the intervention. The study aims to explore the underlying neural mechanisms of NSSI using magnetic resonance imaging (MRI) alongside neuropsychological evaluations. Participants will be randomized to ensure the reliability of results.
Why it matters
Potential benefit: If successful, this intervention could provide a novel non-invasive treatment option for adolescents struggling with non-suicidal self-injury.
How similar studies have gone: While the use of HD-tACS is a relatively novel approach, preliminary studies in related areas suggest potential benefits, though this specific application is less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The patients were diagnosed by 2 or more senior clinical psychiatrists, meeting DSM-V criteria, and having 1 or more non-suicidal self-injurious behaviors in the last 6 months. 12-18 years of age. The medicine has not changed in the 4 weeks prior to or after this study, and if it has to be changed, the treatment medication is required to be at a subtherapeutic dosage level. Exclusion Criteria: The patient has suicidal ideation or has committed suicidal behavior T1 or T2 weighted phase magnetic resonance images show focal brain lesions patients had neurological disorders such as epilepsy, or serious physical illnesses patients had a history of substance abuse and drug dependence in the last 6 months or use of anticonvulsant drugs in the last 3 months patients had received radial cranial electrical stimulation or magnetic stimulation treatment in the last 3 months or received electroconvulsive therapy in the last 6 months patients had previous significant head trauma or EEG abnormality in the last 1 month body-mounted devices unsuitable for treatment, such as pacemakers, artificial valves, and other metal implants.
Where it's running
-
Anhui Medical University
Hefei, Anhui, China Recruiting
Study contacts
- Study coordinator: Kai Wang, PhD
- Email: wangkai1964@126.com
- Phone: +86-0551-62923704
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Home-based gamma-tACS with personalized cognitive training for mild Alzheimer's disease
This study tests a home-delivered combination of gamma-frequency tACS and individualized memory training to see if it helps people with mild Alzheimer's disease.
-
Temporal interference stimulation for non‑suicidal self‑injury in adolescent depression
This trial will test whether temporal interference stimulation (TIS) can reduce non‑suicidal self‑injury in adolescents and young adults (ages 12–22) with major depressive disorder compared with a sham treatment.
-
Beta-frequency brain stimulation for frontotemporal dementia
This trial will try a single session of beta-frequency transcranial alternating current stimulation (tACS) to see if it is safe and can improve brain rhythms and symptoms in people over 40 with frontotemporal dementia.
-
Ear vagus nerve priming plus gentle alternating brain stimulation for teens with non-suicidal self-injury
This study will test whether brief transcutaneous auricular vagus nerve stimulation (taVNS) given before mild 10 Hz transcranial alternating current stimulation (tACS) over the left dlPFC can reduce self-injury-related attention biases, impulsivity, and self-injury behaviors in adolescents aged 12–18 with non-suicidal
-
Alternating electrical brain stimulation for Lewy body dementia
This will test whether mild alternating electrical stimulation of the brain (tACS) is safe and can improve thinking, memory, and visual‑spatial skills in adults with Lewy body dementia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.